Idera Pharmaceuticals, Inc.

IDRA · NASDAQ
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Assets
Cash & Equivalents$2,118$12,044$26,795$24,480
Short-Term Investments$0$0$0$0
Receivables$2,203$4,208$1,964$0
Inventory$0$0$0$0
Other Curr. Assets$1,315$1,611$1,311$1,111
Total Curr. Assets$5,636$17,863$30,070$25,591
Property Plant & Equip (Net)$475$544$611$645
Goodwill$4,629$11,100$9,934$0
Intangibles$67,000$71,600$63,067$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$752$0$0$70
Total NC Assets$72,856$83,244$73,612$715
Other Assets$0$0$0$0
Total Assets$78,492$101,107$103,682$26,306
Liabilities
Payables$3,409$5,200$6,761$148
Short-Term Debt$223$234$245$218
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,231$15,989$12,225$4,370
Total Curr. Liab.$17,863$21,423$19,231$4,736
LT Debt$271$326$380$438
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$3,010$3,283$3,895$0
Other NC Liab.$34,800$37,141$59,408$0
Total NC Liab.$38,081$40,750$63,683$438
Other Liabilities$0$0$0$0
Cap. Leases$494$560$625$656
Total Liabilities$55,944$62,173$82,914$5,174
Equity
Pref Stock$34,800$0$20,400$0
Common Stock$8$4$59$53
Retained Earnings-$780,688-$758,821-$748,045-$744,946
AOCI-$23$0$0$0
Other Equity$768,451$770,643$748,354$766,025
Total Equity$22,548$11,826$20,768$21,132
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$78,492$73,999$103,682$26,306
Net Debt-$1,624-$11,484-$26,170-$23,824